(19)
(11) EP 2 205 244 A1

(12)

(43) Date of publication:
14.07.2010 Bulletin 2010/28

(21) Application number: 08847113.1

(22) Date of filing: 07.11.2008
(51) International Patent Classification (IPC): 
A61K 31/5377(2006.01)
A61P 35/02(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2008/012539
(87) International publication number:
WO 2009/061446 (14.05.2009 Gazette 2009/20)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 08.11.2007 US 2583
07.12.2007 US 5803
19.09.2008 US 98676
06.11.2008 US 112060

(71) Applicant: Ambit Biosciences Corporation
San Diego, CA 92121 (US)

(72) Inventors:
  • JAMES, Joyce, K.
    San Diego CA 92109 (US)
  • EICHELBERGER, Shawn R.
    San Diego, CA 92121 (US)
  • SAVALL, Traci L.
    San Diego, CA 92121 (US)

(74) Representative: Ritter, Thomas Kurt 
Jones Day Prinzregentenstraße 11
80538 München
80538 München (DE)

   


(54) METHODS OF ADMINISTERING N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N'-{4-Ý7-(2-MORPHOLIN-4-YL-ETHOXY)IMIDAZOÝ2,1-B¨Ý1,3¨BENZOTHIAZOL-2-YL¨PHENYL}UREA TO TREAT PROLIFERATIVE DISEASE